Skip to search formSkip to main contentSkip to account menu

myristoylated protein kinase A inhibitor amide 14-22

Known as: myristoylated PKI 14-22 amide, PKI 14-22 amide, Myr-N-Gly-Arg-Thr-Gly-Arg-Arg-Asn-Ala-Ile-NH2 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Carrier ProteinsPeptide Fragments

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Intrathecal injection of selected peptide Myr-RC-13 attenuates bone cancer pain by inhibiting KIF17 and NR2B expression
2011
2011
Myristoylated peptides potentiate the funny current (If) in sinoatrial myocytes
The funny current, If, in sinoatrial myocytes is thought to contribute to the sympathetic fight-or-flight increase in heart rate… 
2011
2011
Effects of local dipoles on the chiroptical properties of chiral oligo(phenyleneethynylene)s: Large
2004
2004
Quantal size of catecholamine release from rat chromaffin cells is regulated by tonic activity of protein kinase A
2003
2003
Distinct Isoforms of Protein Kinase C Are Involved in Human Eosinophil Functions Induced by Platelet-Activating Factor
Background: Platelet-activating factor (PAF) is a potent stimulator of eosinophils. Recently, treatment with a protein kinase C… 
2002
2002
A Better Use of Smart Cards in PKIs ( Extended Abstract ) ?
Public-key cryptography faces the problem of the authentication of the public keys: How do we can be sure that a pair of public… 
1999
1999
N-myristoylation of a peptide substrate for Src converts it into an apparent slow-binding bisubstrate-type inhibitor.
The conversion of a peptide substrate to a potent inhibitor by chemical modification is a promising approach in the development… 
Highly Cited
1998
Highly Cited
1998
2H NMR studies of a myristoylated peptide in neutral and acidic phospholipid bicelles.
Deuterium NMR spectra of Myr-d27-GNAAAAKKGSEQES (Cat14), the N-terminal 14-residue peptide from the catalytic subunit of cAMP… 
1997
1997
Inhibition of phosphoinositide hydrolysis and cell growth of Swiss 3T3 cells by myristoylated phospholipase C inhibitor peptides.
It has been demonstrated that the phospholipase C-gamma (PLC-gamma) molecule contains within it a phospholipase C inhibitor (PCI… 
1996
1996
Growth inhibition by phospholipase C inhibitor peptides of colorectal carcinoma cells derived from familial adenomatous polyposis.
We reported previously the enhanced phosphoinositide metabolism and constitutive activation of phosphoinositide-specific… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)